ID   MOLM-17
AC   CVCL_7922
SY   MOLM17
DR   Cosmic; 975276
DR   Cosmic; 1012097
DR   Cosmic; 2306222
DR   Wikidata; Q54906325
RX   PubMed=15863212;
RX   PubMed=16408098;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L076 ! B422
OI   CVCL_L077 ! B423
OI   CVCL_7923 ! MOLM-18
SX   Male
AG   60-61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=15863212; DOI=10.1016/j.leukres.2004.11.024;
RA   Matsuo Y., Drexler H.G., Harashima A., Okochi A., Kojima K.,
RA   Asakura S., Tanimoto M., Orita K.;
RT   "Acute myeloid leukemia cell lines MOLM-17 and MOLM-18 derived from
RT   patient with advanced myelodysplastic syndromes.";
RL   Leuk. Res. 29:701-710(2005).
//
RX   PubMed=16408098; DOI=10.1038/sj.leu.2404081;
RA   Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.;
RT   "JAK2 V617F tyrosine kinase mutation in cell lines derived from
RT   myeloproliferative disorders.";
RL   Leukemia 20:471-476(2006).
//